skip to primary navigationskip to content

Cambridge Infectious Diseases

An Interdisciplinary Research Centre at the University of Cambridge

Studying at Cambridge


Interdisciplinary Infectious Disease Research

The University of Cambridge and its partner organisations (e.g., Babraham Institute, Sanger, EBI, etc.) is already known for academic excellence in infectious disease research and related fields, particularly in Medicine, where we have built the new Capella Infection and Immunity Building, and in Chemistry where screening of large chemical libraries is leading to new developments in antimicrobial therapies. Cambridge Infectious Diseases (CID) is working to capitalise on and extend this expertise by creating novel research through bridging disciplines working on infection diseases.  As one of our elite University-wide Interdisciplinary Research Centers (IRCs), CID is working to build an excellent interdisciplinary research environment and harness collaborative advantage to tackle some of today's global grand research challenges. 

Infectious diseases are a leading cause of mortality worldwide and a major threat to our food supply and natural resources—particularly with the emergence of new and invasive pathogens. Elimination and control of infectious pathogens remains complex and elusive. Unidentified pathogens continue to emerge in increasing number and greater severity requiring intelligent surveillance. Some pathogens, believed to be susceptible to control efforts, have proven to be more difficult to eradicate than anticipated e.g. TB, Malaria. Evolution by pathogens has reduced the efficacy of therapeutic agents, and the economic impact of human and animal pathogens and antimicrobial resistance continues to grow. Infectious diseases remain a critical concern to global food security, as long term and stochastic environmental and climate change events are creating disaster events and shifts in the range of zoonotic hosts such as insects, and as genetic diversity of livestock and crops decreases, increasing risk /susceptibility to novel emerging diseases. In all world sectors, infectious diseases not only severely compromise the health of populations, but also impacts on economic productivity and social stability. As one of the World’s leading Universities, Cambridge has a major role to play in partnerships addressing this challenge.

Explore research themes  >


Research Horizons

Projects, People and Research Groups

Read more

Professor Ian Goodfellow speaks about Ebola laboratory capacity building and science outreach supported by CID

Ethicobots discusses bTB control strategies in Ethiopia